CLINICAL_TRIALS
trial_result
· 2016-04-15
Clinical Trial Update: Prophylactic Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma [Phase 3]
Summary
Phase 3 trial evaluating prophylactic central lymph node dissection in papillary thyroid microcarcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Samsung Medical Center | Conditions: Thyroid Cancer | Phase 3 | Status: COMPLETED